Sanofi India Ltd - Board Meeting Outcome for Board Meeting Outcome For Standalone And Consolidated Financial Results For The Quarter And Year Ended 31St December 2023

We enclose a copy of the Auditor''s report and Audited Standalone and Consolidated Financial Results of the Company for the Financial Year ended 31st December 2023 along with Statement of Assets and Liabilities as on that date and Statement of Cashflows for the year ended 31st December 2023 as required under Regulation 33 of the SEBI (listing Obligations and Disclosure Requirements) Regulations, 2015. Further, the Board has also declared an Interim Dividend of Rs. 50 per equity share and recommended a final dividend of Rs. 117 per equity share.